A detailed history of Clough Capital Partners L P transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clough Capital Partners L P holds 376,952 shares of BMY stock, worth $21.6 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
376,952
Holding current value
$21.6 Million
% of portfolio
2.11%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $14.9 Million - $19.5 Million
376,952 New
376,952 $19.5 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $1.02 Million - $1.13 Million
-16,000 Reduced 29.8%
37,700 $2.41 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $3.53 Million - $4 Million
53,700 New
53,700 $3.72 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $1.35 Million - $1.61 Million
-29,841 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $5.48 Million - $7.11 Million
-112,419 Reduced 79.02%
29,841 $1.55 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $242,836 - $273,900
-4,400 Reduced 3.0%
142,260 $8.83 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $666,996 - $831,336
13,200 Added 9.89%
146,660 $8.12 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $305,592 - $351,798
5,100 Added 3.97%
133,460 $8.44 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $4.05 Million - $4.42 Million
-67,600 Reduced 34.5%
128,360 $7.87 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $10.8 Million - $12.5 Million
195,960
195,960 $12.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.